Back to Search Start Over

Seizure disorders in Systemic Lupus Erythematosus: Results from an international, prospective, inception cohort study

Authors :
Dafna D. Gladman
Kenneth C. Kalunian
Meggan Mackay
Barri J. Fessler
Ann E. Clarke
J. T. Merrill
Manuel Ramos-Casals
Gunnar Sturfelt
Diane L. Kamen
David A. Isenberg
Murat Inanc
Ellen M. Ginzler
Ola Nived
Rosalind Ramsey-Goldman
Christine A. Peschken
Guillermo Ruiz-Irastorza
R. F. van Vollenhoven
Anisur Rahman
Mary Anne Dooley
Vernon T. Farewell
Munther A. Khamashta
Chris Theriault
Kristjan Steinsson
Asad Zoma
Caroline Gordon
Jorge Sanchez-Guerrero
Ian N. Bruce
Graciela S. Alarcón
Kara Thompson
Daniel J. Wallace
Susan Manzi
Paul R. Fortin
Murray B. Urowitz
Cynthia Aranow
S. Sam Lim
Michelle Petri
John G. Hanly
Sang Cheol Bae
Li Su
Juanita Romero-Diaz
Publication Year :
2012

Abstract

The aim of this study was to describe the frequency, attribution, outcome and predictors of seizures in systemic lupus erythematosus (SLE).The Systemic Lupus International Collaborating Clinics, or SLICC, performed a prospective inception cohort study. Demographic variables, global SLE disease activity (SLE Disease Activity Index 2000), cumulative organ damage (SLICC/American College of Rheumatology Damage Index (SDI)) and neuropsychiatric events were recorded at enrolment and annually. Lupus anticoagulant, anticardiolipin, anti-β(2) glycoprotein-I, antiribosomal P and anti-NR2 glutamate receptor antibodies were measured at enrolment. Physician outcomes of seizures were recorded. Patient outcomes were derived from the SF-36 (36-Item Short Form Health Survey) mental component summary and physical component summary scores. Statistical analyses included Cox and linear regressions.The cohort was 89.4% female with a mean follow-up of 3.5±2.9 years. Of 1631 patients, 75 (4.6%) had ≥1 seizure, the majority around the time of SLE diagnosis. Multivariate analysis indicated a higher risk of seizures with African race/ethnicity (HR (CI): 1.97 (1.07 to 3.63); p=0.03) and lower education status (1.97 (1.21 to 3.19); p0.01). Higher damage scores (without neuropsychiatric variables) were associated with an increased risk of subsequent seizures (SDI=1:3.93 (1.46 to 10.55); SDI=2 or 3:1.57 (0.32 to 7.65); SDI≥4:7.86 (0.89 to 69.06); p=0.03). There was an association with disease activity but not with autoantibodies. Seizures attributed to SLE frequently resolved (59/78 (76%)) in the absence of antiseizure drugs. There was no significant impact on the mental component summary or physical component summary scores. Antimalarial drugs in the absence of immunosuppressive agents were associated with reduced seizure risk (0.07 (0.01 to 0.66); p=0.03).Seizures occurred close to SLE diagnosis, in patients with African race/ethnicity, lower educational status and cumulative organ damage. Most seizures resolved without a negative impact on health-related quality of life. Antimalarial drugs were associated with a protective effect.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....5f36398e87897e1aa37cf758ebe748dd